Deafness with enalapril and prescription event monitoring

Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan.

Pharmacoepidemiology and drug safety·2004

Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization data.

Pharmacoepidemiology and drug safety·2002

Could conditional release of new drugs provide the information required to study drug effectiveness? - A discussion paper.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2000

Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations.

Canadian journal of public health = Revue canadienne de sante publique·2000

New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2000

Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2000

Migraine.

Lancet (London, England)·2026

The public health challenges of children's and adolescents' digital media use: applying the digital determinants of health as an interpretive framework.

Lancet (London, England)·2026

Governing the digital determinants of health for children and young people: a global public health imperative.

Lancet (London, England)·2026

The digital determinants of health: a new era for global public health.

Lancet (London, England)·2026

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

Impact of policy shifts and festival holidays on tuberculosis surveillance: a time-series analysis in Southwest China (2014-2024).

Frontiers in public health·2026

From histological recovery to residual gastric cancer risk after Helicobacter pylori eradication: a multi-database bibliometric and clinical decision-domain analysis.

Frontiers in medicine·2026

Blood transcriptomic immune signatures in herpes zoster and postherpetic neuralgia: parallel cohort analyses of IFN-related pathway patterns.

Frontiers in cellular and infection microbiology·2026

Atopic Dermatitis and Sleep Disorders.

Allergy, asthma & immunology research·2026

Visibility of the Korean National Health Information Portal across search engines and generative artificial intelligence platforms: a repeated cross-sectional study.

Osong public health and research perspectives·2026

Skin Disease After Refugee Resettlement: A Practical 90-Day Approach for Dermatologists and Primary Care Physicians.

International journal of dermatology·2026

Related Experiment Videos

Deafness with enalapril and prescription event monitoring

Related Concept Videos

Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan.

Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization data.

Could conditional release of new drugs provide the information required to study drug effectiveness? - A discussion paper.

Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations.

New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.

Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998.

Migraine.

The public health challenges of children's and adolescents' digital media use: applying the digital determinants of health as an interpretive framework.

Governing the digital determinants of health for children and young people: a global public health imperative.

The digital determinants of health: a new era for global public health.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Impact of policy shifts and festival holidays on tuberculosis surveillance: a time-series analysis in Southwest China (2014-2024).

From histological recovery to residual gastric cancer risk after Helicobacter pylori eradication: a multi-database bibliometric and clinical decision-domain analysis.

Blood transcriptomic immune signatures in herpes zoster and postherpetic neuralgia: parallel cohort analyses of IFN-related pathway patterns.

Atopic Dermatitis and Sleep Disorders.

Visibility of the Korean National Health Information Portal across search engines and generative artificial intelligence platforms: a repeated cross-sectional study.

Skin Disease After Refugee Resettlement: A Practical 90-Day Approach for Dermatologists and Primary Care Physicians.

Related Experiment Videos

Deafness with enalapril and prescription event monitoring

Related Concept Videos

Related Articles